Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 1s (C1s) is a serine protease and a key enzymatic subunit of the C1 complex, which initiates the classical pathway of the complement system. Activated C1s specifically cleaves complement components C4 and C2, leading to the formation of the classical pathway convertase. Deficiency or dysfunction can result in immunodeficiencies or contribute to autoimmune diseases.
C1s is a serine protease that cleaves complement components C4 and C2, initiating the classical pathway of complement activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component 1s (C1s).